参考文献：
[1] Ayer, J., Charakida, M., Deanfield, J. E., & Celermajer, D. S. (2015). Lifetime risk: childhood obesity and cardiovascular risk. European heart journal, 36(22), 1371–1376.
[2] Burke, G. L., Bertoni, A. G., Shea, S., Tracy, R., Watson, K. E., Blumenthal, R. S., Chung, H., & Carnethon, M. R. (2008). The impact of obesity on cardiovascular disease risk factors and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. Archives of internal medicine, 168(9), 928–935.
[3] Church, T. S., Kuk, J. L., Ross, R., Priest, E. L., Biltoft, E., & Blair, S. N. (2006). Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease. Gastroenterology, 130(7), 2023–2030.
[4] Frühbeck, G., Busetto, L., Dicker, D., Yumuk, V., Goossens, G. H., Hebebrand, J., Halford, J. G. C., Farpour-Lambert, N. J., Blaak, E. E., Woodward, E., & Toplak, H. (2019). The ABCD of Obesity: An EASO Position Statement on a Diagnostic Term with Clinical and Scientific Implications. Obesity facts, 12(2), 131–136.
[5] Rubino, F., Batterham, R. L., Koch, M., Mingrone, G., le Roux, C. W., Farooqi, I. S., Farpour-Lambert, N., Gregg, E. W., & Cummings, D. E. (2023). Lancet Diabetes & Endocrinology Commission on the Definition and Diagnosis of Clinical Obesity. The lancet. Diabetes & endocrinology, 11(4), 226–228.
[6] Bays, H. E., Kirkpatrick, C. F., Maki, K. C., Toth, P. P., Morgan, R. T., Tondt, J., Christensen, S. M., Dixon, D. L., & Jacobson, T. A. (2024). Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024. Journal of clinical lipidology, 18(3), e320–e350.
[7] Bowman-Busato, J., Schreurs, L., Halford, J. C. G., Yumuk, V., O'Malley, G., Woodward, E., De Cock, D., & Baker, J. L. (2024). Providing a common language for obesity: the European Association for the Study of Obesity obesity taxonomy. International journal of obesity (2005),
[8] Reinisch, I., Ghosh, A., Noé, F., Sun, W., Dong, H., Leary, P., Dietrich, A., Hoffmann, A., Blüher, M., & Wolfrum, C. (2024). Unveiling adipose populations linked to metabolic health in obesity. Cell metabolism, S1550-4131(24)00452-2. Advance online publication.
[9] Chen, F., Wang, J., He, S., He, Y., An, Y., Gong, Q., Chen, X., Shuai, Y., Wang, X., Chen, Y., Zhang, B., & Li, G. (2024). Influence of impaired glucose tolerance and type 2 diabetes on the multimorbidity cluster of cardiovascular disease and cancer: a post hoc analysis of the Da Qing Diabetes Prevention Outcome Study. BMC medicine, 22(1), 534.
[10] Gyldenkerne, C., Kahlert, J., Thrane, P. G., Olesen, K. K. W., Mortensen, M. B., Sørensen, H. T., Thomsen, R. W., & Maeng, M. (2024). 2-Fold More Cardiovascular Disease Events Decades Before Type 2 Diabetes Diagnosis: A Nationwide Registry Study. Journal of the American College of Cardiology, 84(23), 2251–2259.
[11] Westaby, J., Dalle-Carbonare, C., Ster, I. C., & Sheppard, M. N. (2023). Obesity Cardiomyopathy in Sudden Cardiac Death: A Distinct Entity? A Comparative Study. JACC. Advances, 2(5), 100414.
[12] Liu, J., Qu, Y., Li, J., He, W., Chen, X., Li, X., Wang, Y., Tang, H., Yuan, Y., Deng, L., Chen, G., Zheng, T., Nie, L., Zhou, X., Song, B., Tong, N., & Peng, L. (2024). Myocardial tissue remodeling in early adult obesity and its association with regional adipose tissue distribution and ectopic fat deposits: a prospective study. European radiology, 34(2), 970–980.
[13] Qu, Y., Liu, J., Li, J., Shen, S., Chen, X., Tang, H., Yuan, Y., Xia, C., Deng, L., Chen, G., Zheng, T., Chen, J., Nie, L., Yuan, F., Tong, N., Peng, L., & Song, B. (2023). Association of abdominal adiposity, hepatic shear stiffness with subclinical left-ventricular remodeling evaluated by magnetic resonance in adults free of overt cardiovascular diseases: a prospective study. Cardiovascular diabetology, 22(1), 99.
[14] Liu, J., Li, J., Pu, H., He, W., Zhou, X., Tong, N., & Peng, L. (2022). Cardiac remodeling and subclinical left ventricular dysfunction in adults with uncomplicated obesity: a cardiovascular magnetic resonance study. Quantitative imaging in medicine and surgery, 12(3), 2035–2050.
[15] Liu, J., Li, J., Yu, J., Xia, C., Pu, H., He, W., Li, X., Zhou, X., Tong, N., & Peng, L. (2022). Regional Fat Distributions Are Associated With Subclinical Right Ventricular Dysfunction in Adults With Uncomplicated Obesity. Frontiers in cardiovascular medicine, 9, 814505.
[16] Tsur, A. M., Akavian, I., Landau, R., Derazne, E., Tzur, D., Vivante, A., Grossman, E., Rotem, R. S., Fishman, B., Pinhas-Hamiel, O., Afek, A., Coresh, J., Chodick, G., & Twig, G. (2024). Adolescent Body Mass Index and Early Chronic Kidney Disease in Young Adulthood. JAMA pediatrics, 178(2), 142–150.
[17] Colhoun, H. M., Lingvay, I., Brown, P. M., Deanfield, J., Brown-Frandsen, K., Kahn, S. E., Plutzky, J., Node, K., Parkhomenko, A., Rydén, L., Wilding, J. P. H., Mann, J. F. E., Tuttle, K. R., Idorn, T., Rathor, N., & Lincoff, A. M. (2024). Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial. Nature medicine, 30(7), 2058–2066.
[18] Zou, Y., Zhao, L., Zhang, J., Wang, Y., Wu, Y., Ren, H., Wang, T., Zhao, Y., Xu, H., Li, L., Tong, N., & Liu, F. (2023). Metabolic-associated fatty liver disease increases the risk of end-stage renal disease in patients with biopsy-confirmed diabetic nephropathy: a propensity-matched cohort study. Acta diabetologica, 60(2), 225–233.
[19] Sharma A. M. (2010). M, M, M & M: a mnemonic for assessing obesity. Obesity reviews : an official journal of the International Association for the Study of Obesity, 11(11), 808–809.
[20] Hosler A. S. (2009). Prevalence of self-reported prediabetes among adults participating in a community-based health awareness program, New York State. Preventing chronic disease, 6(2), A48.
[21] Zhang X, et al. Ann Intern Med. 2019 Oct 29
[22] Metabolism Clinical and Experimental 92 (2019) 6–10.
[23] American Diabetes Association Professional Practice Committee (2024). 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2024. Diabetes care, 47(Suppl 1), S145–S157.
[24] Buch, A., Marcus, Y., Shefer, G., Zimmet, P., & Stern, N. (2021). Approach to Obesity in the Older Population. The Journal of clinical endocrinology and metabolism, 106(9), 2788–2805.
[25] Gruberg, L., Weissman, N. J., Waksman, R., Fuchs, S., Deible, R., Pinnow, E. E., Ahmed, L. M., Kent, K. M., Pichard, A. D., Suddath, W. O., Satler, L. F., & Lindsay, J., Jr (2002). The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox?. Journal of the American College of Cardiology, 39(4), 578–584.
[26] Antonopoulos, A. S., & Tousoulis, D. (2017). The molecular mechanisms of obesity paradox. Cardiovascular research, 113(9), 1074–1086.
